Adverse Events

ALPROLIX^® is generally well-tolerated¹

The table lists adverse reactions reported in the clinical studies and identified in post-marketing use

MedDRA, Medical Dictionary for Regulatory Activities.

*Common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100).¹ ^†Adverse drug reaction and frequency calculations are based on occurrence in PUPs only. Both factor IX inhibition and hypersensitivity occured in a single PUP.¹

Reference

ALPROLIX^® Summary of Product Characteristics 2021. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/alprolix. Accessed May 2021.